Anthony Adamis
Net worth: - $ as of 30/06/2026
Net worth: - $ as of 30/06/2026
Anthony P.
Adamis is the founder of Eyebiotech Ltd., founded in 2021, where the title held is Director.
Current jobs include Independent Director at Spiral Therapeutics, Inc. since 2021; Director at Gyroscope Therapeutics Ltd. since 2021; Director at Kalaris TX, Inc. since 2021; Director at Retinal Degeneration Fund since 2021; Independent Director at Kalaris Therapeutics, Inc. since 2025; and Chief Scientific Officer at (OSI) Eyetech.
Former jobs include Director at Gyroscope Therapeutics Holdings Plc from 2021 to 2022; Independent Director at EyePoint, Inc. from 2022 to 2024; Chief Scientific Officer at Oldtech, Inc.; and Vice President & Global Head-Ophthalmology at Genentech, Inc. from 2009 to 2021.
Education includes undergraduate studies at the University of Illinois and a doctorate from Pritzker School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 03/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Chief Tech/Sci/R&D Officer | - |
Retinal Degeneration Fund
Retinal Degeneration Fund Investment Trusts/Mutual FundsMiscellaneous Operates as a fund focuses on making mission-related investments in companies with projects nearing clinical testing | Director/Board Member | 01/10/2021 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Director/Board Member | 01/12/2021 |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Operates as a clinical stage ophthalmology company which treats patients with sight threatening diseases | Founder | 09/07/2021 |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage company focuses on delivering therapies for inner ear disorder | Director/Board Member | 01/10/2021 |
Theia Therapeutics, Inc.
Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Director/Board Member | 01/11/2021 |
| Companies | Position | End |
|---|---|---|
| EYEPOINT, INC. | Director/Board Member | 03/09/2024 |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 17/02/2022 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2021 |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage company focuses on delivering therapies for inner ear disorder | Commercial Services |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Retinal Degeneration Fund
Retinal Degeneration Fund Investment Trusts/Mutual FundsMiscellaneous Operates as a fund focuses on making mission-related investments in companies with projects nearing clinical testing | Miscellaneous |
Theia Therapeutics, Inc.
Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Operates as a clinical stage ophthalmology company which treats patients with sight threatening diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions